SCHEMBL19244117

SCHEMBL19244117

Bc1ccc(CCCCCCCCCC)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 2/20 0.63
▸ ADRA2A P08913 2/20 0.63
▸ ADORA3 P0DMS8 2/20 0.63
▸ TACR2 P21452 2/20 0.63
▸ SLC6A2 P23975 2/20 0.63
▸ SLC6A4 P31645 2/20 0.63
▸ SLC6A3 Q01959 2/20 0.63
▸ ALDH1A1 P00352 2/20 0.63
▸ HSD17B10 Q99714 2/20 0.63
▸ KDM4E B2RXH2 1/20 0.63
▸ LMNA P02545 1/20 0.63
▸ SHBG P04278 1/20 0.63
▸ TP53 P04637 1/20 0.63
▸ CYP3A4 P08684 1/20 0.63
▸ HSPD1 P10809 1/20 0.63
▸ ADRB3 P13945 1/20 0.63
▸ HTR2C P28335 1/20 0.63
▸ HSPE1 P61604 1/20 0.63
▸ HIF1A Q16665 1/20 0.63
▸ TST Q16762 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL339558 1.00 ESR1 (0.63) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL12269093 1.00 ESR1 (0.63) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL13182976 1.00 ESR1 (0.63) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL12269221 0.98 ESR1 (0.59) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL12966255 0.91 RARB (0.58) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL15868702 0.91 CA2 (0.54) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL23849704 0.88 ESR1 (0.77) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL11094076 0.88 ESR1 (0.77) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL1412742 0.88 ESR1 (0.77) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL6683955 0.88 ESR1 (0.77) ESR1ADRA2AADORA3TACR2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023196527-A2 IONIZABLE LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS SunVax mRNA Therapeutics Inc. (US) 2023-10-12 — — WO disclosed
EP-3208273-B1 ORGANIC SEMICONDUCTOR ELEMENT AND PRODUCTION METHOD FOR SAME, ORGANIC SEMICONDUCTOR COMPOSITION, ORGANIC SEMICONDUCTOR FILM, COMPOUND, AND OLIGOMER OR POLYMER FUJIFILM CORP (JP) 2019-07-10 — — EP disclosed
US-9954172-B2 Organic semiconductor element, manufacturing method thereof, organic semiconductor composition, organic semiconductor film, compound, and oligomer or polymer FUJIFILM CORPORATION (JP) 2018-04-24 — — US disclosed
US-20170250345-A1 ORGANIC SEMICONDUCTOR ELEMENT, MANUFACTURING METHOD THEREOF, ORGANIC SEMICONDUCTOR COMPOSITION, ORGANIC SEMICONDUCTOR FILM, COMPOUND, AND OLIGOMER OR POLYMER FUJIFILM CORPORATION (JP) 2017-08-31 — — US disclosed
EP-3208273-A1 ORGANIC SEMICONDUCTOR ELEMENT AND PRODUCTION METHOD FOR SAME, ORGANIC SEMICONDUCTOR COMPOSITION, ORGANIC SEMICONDUCTOR FILM, COMPOUND, AND OLIGOMER OR POLYMER Fujifilm Corporation (JP) 2017-08-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250345-A1 ORGANIC SEMICONDUCTOR ELEMENT, MANUFACTURING METHOD THEREOF, ORGANIC SEMICONDUCTOR COMPOSITION, ORGANIC SEMICONDUCTOR FILM, COMPOUND, AND OLIGOMER OR POLYMER SLCO2A1, PROX1, POLQ ESR1 1810/4885ADRA2A 4525/4885ADORA3 4379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback